Department of Respiratory & Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Chongqing Key Laboratory of Molecular Oncology & Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Epigenomics. 2020 Oct;12(20):1793-1810. doi: 10.2217/epi-2020-0157. Epub 2020 Oct 5.
To explore the biological functions and clinical significance of in lung cancer. Methylation-specific PCR was used to measure promoter methylation of . The function of was tested by Cell Counting Kit-8, colony formation, Transwell, flow cytometric analysis, acridine orange/ethidium bromide, chemosensitivity assay and xenograft assay. is significantly downregulated by promoter methylation in lung cancer. overexpression inhibits lung cancer cell migration and invasion. Furthermore, ectopic expression of inhibits cell proliferation and by inducing G2/M cell cycle arrest, which sensitizes the chemosensitivity of lung cancer cells to paclitaxel and 5-fluorouracil, but not cisplatin. is a tumor suppressor in non-small-cell lung cancer and can sensitize lung cancer cells to paclitaxel and 5-fluorouracil.
探讨 在肺癌中的生物学功能和临床意义。采用甲基化特异性 PCR 检测 的启动子甲基化。通过细胞计数试剂盒-8、集落形成、Transwell、流式细胞术分析、吖啶橙/溴化乙锭、化疗敏感性测定和异种移植测定来检测 的功能。 在肺癌中, 因启动子甲基化而显著下调。 过表达抑制肺癌细胞迁移和侵袭。此外,外源性表达 可通过诱导 G2/M 细胞周期阻滞来抑制细胞增殖和 ,从而使肺癌细胞对紫杉醇和 5-氟尿嘧啶的化疗敏感性增加,但对顺铂不敏感。 在非小细胞肺癌中是一种肿瘤抑制因子,可使肺癌细胞对紫杉醇和 5-氟尿嘧啶敏感。